Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 921080, 8 pages
http://dx.doi.org/10.1155/2014/921080
Research Article

Kolaviron Improved Resistance to Oxidative Stress and Inflammation in the Blood (Erythrocyte, Serum, and Plasma) of Streptozotocin-Induced Diabetic Rats

1Nutrition and Chronic Disease Research Unit, Oxidative Stress Research Centre, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Bellville, South Africa
2Department of Wellness Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Cape Town, South Africa

Received 4 January 2014; Accepted 17 February 2014; Published 24 March 2014

Academic Editors: C. M. Davis, E. Hopper-Borge, and C.-P. Wu

Copyright © 2014 Omolola R. Ayepola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. L. Baggio and D. J. Drucker, “Biology of Incretins: GLP-1 and GIP,” Gastroenterology, vol. 132, no. 6, pp. 2131–2157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Rösen, P. P. Nawroth, G. King, W. Möller, H.-J. Tritschler, and L. Packer, “The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American diabetes association and the German diabetes society,” Diabetes/Metabolism Research and Reviews, vol. 17, no. 3, pp. 189–212, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes,” Endocrine Reviews, vol. 23, no. 5, pp. 599–622, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Bahorun, M. Soobrattee, V. Luximon-Ramma, and O. Aruoma, “Free radicals and antioxidants in cardiovascular health and disease,” Internet Journal of Medical Update, vol. 1, no. 2, pp. 25–41, 2006. View at Google Scholar
  6. B. Halliwell, “Biochemistry of oxidative stress,” Biochemical Society Transactions, vol. 35, part 5, pp. 1147–1150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. B. Pandey and S. I. Rizvi, “Biomarkers of oxidative stress in red blood cells,” Biomedical Papers, vol. 155, no. 2, pp. 131–136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Comazzi, V. Spagnolo, and U. Bonfanti, “Erythrocyte changes in canine diabetes mellitus: in vitro effects of hyperglycaemia and ketoacidosis,” Comparative Clinical Pathology, vol. 12, no. 4, pp. 199–205, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Dallak and I. Bin-Jaliah, “Antioxidant activity of Citrulluscolocynthis pulp extract in the RBC’s of alloxan-induced diabetic rats,” Pakistan Journal of Physiology, vol. 6, no. 1, pp. 112–122, 2010. View at Google Scholar
  10. K. Kolanjiappan, S. Manoharan, and M. Kayalvizhi, “Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients,” Clinica Chimica Acta, vol. 326, no. 1-2, pp. 143–149, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Kiritoshi, T. Nishikawa, K. Sonoda et al., “Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy,” Diabetes, vol. 52, no. 10, pp. 2570–2577, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Baynes, “Chemical modification of proteins by lipids in diabetes,” Clinical Chemistry and Laboratory Medicine, vol. 41, no. 9, pp. 1159–1165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. P. Wolff, “Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications,” British Medical Bulletin, vol. 49, no. 3, pp. 642–652, 1993. View at Google Scholar · View at Scopus
  14. A. Griesmacher, M. Kindhauser, S. E. Andert et al., “Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus,” American Journal of Medicine, vol. 98, no. 5, pp. 469–475, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. J. F. Navarro-González, C. Mora-Fernández, M. M. de Fuentes, and J. García-Pérez, “Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy,” Nature Reviews Nephrology, vol. 7, no. 6, pp. 327–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R.-E. W. Kavey, V. Allada, S. R. Daniels et al., “Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Paediatrics,” Circulation, vol. 114, no. 24, pp. 2710–2738, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Terashima, Y. Takaya, and M. Niwa, “Powerful antioxidative agents based on garcinoic acid from Garcinia kola,” Bioorganic and Medicinal Chemistry, vol. 10, no. 5, pp. 1619–1625, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. B. Olaleye, E. O. Farombi, E. A. Adewoye, B. V. Owoyele, S. A. Onasanwo, and R. A. Elegbe, “Analgesic and anti-inflammatory effects of kolaviron (a Garcinia kola seed extract),” African Journal of Biomedical Research, vol. 3, pp. 171–174, 2000. View at Google Scholar
  19. E. O. Farombi, B. F. Adepoju, O. E. Ola-Davies, and G. O. Emerole, “Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, a natural biflavonoid of Garcinia kola seeds,” European Journal of Cancer Prevention, vol. 14, no. 3, pp. 207–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. E. O. Farombi, S. Shrotriya, and Y.-J. Surh, “Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-κB and AP-1,” Life Sciences, vol. 84, no. 5-6, pp. 149–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. I. A. Adedara and E. O. Farombi, “Chemoprotection of ethylene glycol monoethyl ether-induced reproductive toxicity in male rats by kolaviron, isolated biflavonoid from Garcinia kola seed,” Human and Experimental Toxicology, vol. 31, pp. 506–517, 2012. View at Google Scholar
  22. E. O. Farombi, I. A. Adedara, B. O. Ajayi, O. R. Ayepola, and E. E. Egbeme, “Kolaviron, a natural antioxidant and anti-inflammatory phytochemical prevents dextran sulphate sodium-induced colitis in rats,” Basic and Clinical Pharmacology and Toxicology, vol. 113, no. 1, pp. 49–55, 2013. View at Google Scholar
  23. M. M. Iwu, O. A. Igboko, C. O. Okunji, and M. S. Tempesta, “Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola,” Journal of Pharmacy and Pharmacology, vol. 42, no. 4, pp. 290–292, 1990. View at Google Scholar · View at Scopus
  24. I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Ou, M. Hampsch-Woodill, and R. L. Prior, “Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe,” Journal of Agricultural and Food Chemistry, vol. 49, no. 10, pp. 4619–4626, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. V. L. Singleton, R. Orthofer, and R. M. Lamuela-Raventós, “Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent,” Methods in Enzymology, vol. 299, pp. 152–178, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Crosti, T. Servidei, J. Bajer, and A. Serra, “Modification of the 6-hydroxydopamine technique for the correct determination of superoxide dismutase,” Journal of Clinical Chemistry and Clinical Biochemistry, vol. 25, no. 4, pp. 265–266, 1987. View at Google Scholar · View at Scopus
  29. L. M. Ellerby and D. E. Bredesen, “Measurement of cellular oxidation, reactive oxygen species, and antioxidant enzymes during apoptosis,” Methods in Enzymology, vol. 322, pp. 413–421, 2000. View at Google Scholar · View at Scopus
  30. G. A. Khoschsorur, B. M. Winklhofer-Roob, H. Rabl, T. Auer, Z. Peng, and R. J. Schaur, “Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials,” Chromatographia, vol. 52, no. 3-4, pp. 181–184, 2000. View at Google Scholar · View at Scopus
  31. O. R. Ayepola, N. N. Chegou, N. L. Brooks, and O. O. Oguntibeju, “Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses,” BMC Complementary and Alternative Medicine, vol. 13, article 363, 2013. View at Google Scholar
  32. P. Yadav, S. Sarkar, and D. Bhatnagar, “Lipid peroxidation and antioxidant enzymes in erythrocytes and tissues in aged diabetic rats,” Indian Journal of Experimental Biology, vol. 35, no. 4, pp. 389–392, 1997. View at Google Scholar · View at Scopus
  33. C. Huang, Y. Kim, M. L. A. Caramori et al., “Cellular basis of diabetic nephropathy: II. The transforming growth factor-β system and diabetic nephropathy lesions in type 1 diabetes,” Diabetes, vol. 51, no. 12, pp. 3577–3581, 2002. View at Google Scholar · View at Scopus
  34. J. Y. Kim, S. H. Lee, E. H. Song et al., “A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3,” Cellular Signalling, vol. 21, no. 12, pp. 1758–1767, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. S. A. Harrison, “Liver disease in patients with diabetes mellitus,” Journal of Clinical Gastroenterology, vol. 40, no. 1, pp. 68–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. I. N. Zelko, T. J. Mariani, and R. J. Folz, “Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression,” Free Radical Biology and Medicine, vol. 33, no. 3, pp. 337–349, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Jurkovič, J. Osredkar, and J. Marc, “Molecular impact of glutathione peroxidases in antioxidant processes,” Biochemia Medica, vol. 18, no. 2, pp. 162–174, 2008. View at Google Scholar · View at Scopus
  38. A. Seven, S. Güzel, O. Seymen et al., “Effects of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma,” Yonsei Medical Journal, vol. 45, no. 4, pp. 703–710, 2004. View at Google Scholar · View at Scopus
  39. K. Hamden, S. Carreau, K. Jamoussi et al., “1α,25 dihydroxyvitamin D3: therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats,” Journal of Nutritional Science and Vitaminology, vol. 55, no. 3, pp. 215–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Likidlilid, N. Patchanans, T. Peerapatdit, and C. Sriratanasathavorn, “Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients,” Journal of the Medical Association of Thailand, vol. 93, no. 6, pp. 682–693, 2010. View at Google Scholar · View at Scopus
  41. K. Z. Kȩdziora-Kornatowska, M. Luciak, J. Blaszczyk, and W. Pawlak, “Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy,” Nephrology Dialysis Transplantation, vol. 13, no. 11, pp. 2829–2832, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Bandeira, S. Guedes, L. J. da Fonseca et al., “Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 819310, 13 pages, 2012. View at Publisher · View at Google Scholar
  43. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Corradini, P. Foglia, P. Giansanti, R. Gubbiotti, R. Samperi, and A. Laganà, “Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants,” Natural Product Research, vol. 25, no. 5, pp. 469–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. E. O. Farombi and I. A. Nwaokeafor, “Anti-oxidant mechanisms of kolaviron: studies on serum lipoprotein oxidation, metal chelation and oxidative membrane damage in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 32, no. 8, pp. 667–674, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. E. O. Farombi, S. O. Abarikwu, I. A. Adedara, and M. O. Oyeyemi, “Curcumin and kolaviron ameliorate di-n-butylphthalate-induced testicular damage in rats,” Basic and Clinical Pharmacology and Toxicology, vol. 100, no. 1, pp. 43–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Betteridge, “Lipid disorders in diabetes mellitus,” in Text Book of Diabetes, J. C. Pickup and G. Williams, Eds., pp. 1–35, Blackwell Science, London, UK, 2nd edition, 1997. View at Google Scholar
  48. K. Esposito, F. Nappo, R. Marfella et al., “Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress,” Circulation, vol. 106, no. 16, pp. 2067–2072, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. A. A. Elmarakby and J. C. Sullivan, “Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy,” Cardiovascular Therapeutics, vol. 30, no. 1, pp. 49–59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. G. P. A. Vadla and E. Vellaichamy, “Beneficial effects of aminoguanidine against streptozotocin-induced pathological changes in diabetic mice kidney,” Biomedicine & Preventive Nutrition, vol. 3, no. 3, pp. 221–226, 2012. View at Google Scholar
  51. F. Santilli, A. Spagnoli, A. Mohn et al., “Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3871–3876, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. G. H. Tesch, “MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy,” American Journal of Physiology—Renal Physiology, vol. 294, no. 4, pp. F697–F701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Palsamy and S. Subramanian, “Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling,” Biochimica et Biophysica Acta, vol. 1812, no. 7, pp. 719–731, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Takahashi and M. Shibuya, “The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions,” Clinical Science, vol. 109, no. 3, pp. 227–241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. F. Chiarelli, A. Spagnoli, F. Basciani et al., “Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications,” Diabetic Medicine, vol. 17, no. 9, pp. 650–656, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Chen and F. N. Ziyadeh, “Vascular endothelial growth factor and diabetic nephropathy,” Current Diabetes Reports, vol. 8, no. 6, pp. 470–476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Xing and D. G. Remick, “Promoter elements responsible for antioxidant regulation of MCP-1 gene expression,” Antioxidants and Redox Signaling, vol. 9, no. 11, pp. 1979–1989, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. D. J. Lefer and D. N. Granger, “Monocyte rolling in early atherogenesis vital role in lesion development,” Circulation Research, vol. 84, no. 11, pp. 1353–1355, 1999. View at Google Scholar · View at Scopus
  59. K. Egashira, “Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1,” Hypertension, vol. 41, no. 3, pp. 834–841, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Y. Chow, D. J. Nikolic-Paterson, E. Ozols, R. C. Atkins, B. J. Rollin, and G. H. Tesch, “Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice,” Kidney International, vol. 69, no. 1, pp. 73–80, 2006. View at Publisher · View at Google Scholar · View at Scopus